BSc (Econ)(Hons) Economics, Finance and Management
Spanning three years, with options to extend to four or five years to include a year ab...
MSc Cancer and Molecular Pathology and Genomics
Charterhouse Square
INTAKE: September
Program Overview
The MSc in Cancer and Molecular Pathology and Genomics at Queen Mary University of London focuses on the molecular mechanisms of cancer, including the role of genetics in tumorigenesis. The program offers an interdisciplinary approach that blends pathology with genomics to give students a thorough understanding of how molecular diagnostics are used in clinical settings. With a focus on translating scientific discoveries into clinical practice, students will be prepared to contribute to the growing field of personalized medicine, specifically in the context of oncology.
Curriculum: The curriculum is designed to provide students with a comprehensive understanding of molecular pathology and cancer genomics. Core modules include Cancer Biology, Molecular Pathology, Genomics in Medicine, and Cancer Therapeutics. These modules provide students with a strong foundation in cancer's genetic and molecular underpinnings, preparing them for advanced research in cancer biology. Additionally, students will gain hands-on experience in laboratory techniques and data analysis through practical sessions and a dissertation project. This ensures that they are equipped with both theoretical knowledge and practical expertise to address real-world challenges in cancer research and treatment.
Research Focus: Queen Mary University of London’s research in cancer and genomics is focused on the molecular mechanisms that drive cancer progression, with a particular emphasis on how genetic alterations contribute to cancer’s development and resistance to treatment. The university’s Barts Cancer Institute is at the forefront of pioneering research into cancer genomics and molecular pathology. Students in this program will have the opportunity to engage with ongoing research projects, learning from leading experts and contributing to groundbreaking discoveries in the field of cancer genomics, early diagnosis, and targeted therapies.
Industry Engagement: The MSc program benefits from Queen Mary’s strong connections to the healthcare and pharmaceutical industries. Students are exposed to real-world applications through collaborations with hospitals, research institutions, and industry partners. This engagement ensures that students not only gain academic knowledge but also understand how their learning can be applied in clinical and commercial settings. Queen Mary's close ties with industry also offer valuable opportunities for networking, internships, and career progression in areas such as diagnostics, drug development, and personalized cancer therapies.
Global Perspective: Queen Mary University of London is a highly international institution, attracting students and faculty from all over the world. The MSc in Cancer and Molecular Pathology and Genomics reflects a global approach to cancer research and treatment, incorporating diverse perspectives and methodologies. The university fosters an inclusive learning environment, preparing students to tackle cancer-related challenges in a global context. As cancer is a worldwide issue, the program emphasizes the importance of international collaborations and understanding the varying challenges and solutions in cancer treatment across different regions.
Location
Charterhouse Square
Score
IELTS 6.5
Tuition Fee
£ 29950
Postgraduate Entry Requirements:
- Applicants should have successfully completed a bachelor's degree or its equivalent from a recognized institution with a minimum overall score of 60% or equivalent.
- English language proficiency is required, and applicants must provide evidence of their English language skills through an approved language test.
- IELTS: A minimum overall score of 6.5 with no individual component below 6.0.
- TOEFL: A minimum overall score of 92, with at least with at least 17 in Listening, 18 in Reading, 20 in Speaking, and 21 in Writing.
- PTE Academic: A minimum overall score of 71 with 65 in Writing, and 59 in Reading, Listening and Speaking..
- Some postgraduate programs may have specific subject prerequisites or additional requirements.
Students must provide:
- academic marksheets & transcripts
- letters of recommendation
- a personal statement - SOP
- passport
- other supporting documents as required by the university.
Work experience: Some postgraduate courses may require relevant work experience in the field.
It is important to note that meeting the minimum entry requirements does not guarantee admission, as the university considers factors such as availability of places and competition for the program. Additionally, some courses may have higher entry requirements or additional selection criteria, such as interviews or portfolio submissions.
Queen Mary University of London offers a range of scholarships and bursaries to its students.
Queen Mary International Excellence Scholarships: A scholarship program for international undergraduate and postgraduate students who have an offer of admission from Queen Mary University of London and have demonstrated academic excellence. The scholarship covers full tuition fees for one year of study.
Queen Mary Law Scholarships: A scholarship program for undergraduate and postgraduate law students who have an offer of admission from Queen Mary University of London and have demonstrated academic excellence. The scholarship covers full or partial tuition fees, depending on the level of academic achievement.
Queen Mary Engineering and Materials Science Scholarships: A scholarship program for undergraduate and postgraduate students studying engineering or materials science who have an offer of admission from Queen Mary University of London and have demonstrated academic excellence. The scholarship covers full or partial tuition fees, depending on the level of academic achievement.
Graduates of the MSc in Cancer and Molecular Pathology and Genomics program are poised to make substantial contributions to the field of cancer research and diagnostics. This program opens doors to diverse career opportunities.
Cancer Research Scientist: Graduates can pursue research positions in academic institutions, biotechnology companies, and pharmaceutical firms, contributing to advancements in cancer understanding.
Molecular Pathologist: Graduates may specialize in molecular pathology, analyzing genetic and molecular alterations in tissue samples to aid in cancer diagnosis and treatment planning.
Genomic Data Analyst: Graduates can apply their expertise to analyze and interpret genomic data, uncovering insights into cancer genetics and molecular pathways.
Clinical Laboratory Scientist: Graduates may work in clinical laboratories, conducting molecular tests and contributing to patient care through accurate cancer diagnosis and prognosis.
Biomedical Consultant: Graduates may provide consulting services to healthcare organizations, offering insights into the integration of genomics technologies in clinical practice.
Biotech and Pharmaceutical Industry: Graduates can engage in drug discovery and development, contributing to the design and testing of targeted therapies based on genomic insights.
Academic Educator: Graduates with a passion for education may pursue careers as educators, sharing their expertise in cancer genomics with the next generation of scientists.
Cancer Diagnostics and Pathology Services: Graduates can contribute to cancer diagnostics and pathology services, working alongside healthcare professionals to provide accurate and timely diagnoses.
Health Policy and Advocacy: Graduates may engage in health policy and advocacy initiatives, influencing the integration of genomics technologies into healthcare systems.
Further Studies: Graduates may choose to pursue doctoral studies (Ph.D.) in cancer genomics or related fields, advancing their expertise and making significant contributions to research.
